Displaying drugs 14601 - 14625 of 15379 in total
4-(3-ethylthiophen-2-yl)benzene-1,2-diol
Experimental
1-Naphthylamine-5-sulfonic acid
Experimental
5-aminonaphthalene-2-sulfonic acid
Experimental
Sambucus nigra flowering top
Experimental
Bacillus subtilis
Experimental
Lactobacillus helveticus
Experimental
Magnolia kobus bark
Experimental
Anemarrhena asphodeloides root
Experimental
Polygala tenuifolia root
Experimental
Minretumomab
Experimental
AMP-224
Investigational
Anise oil
Experimental
Alpinia officinarum leaf
Experimental
BacTRL-spike
BacTRL-Spike is composed of a bacterial medium with colony-forming-units of live Bifidobacterium longum engineered to deliver synthetic DNA encoding spike protein from SARS-CoV-2 contained by plasmids. The vaccine was developed by Symvivo Corporation. As of June, 2020, the company is pursuing a Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial (NCT04334980) to...
Investigational
Matched Description: … pursuing a Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial (NCT04334980) to test the safety and …
Cedar leaf oil
Experimental
Cajuput oil
Experimental
Nutmeg oil
Experimental
Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle (VLP) vaccine
Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV-2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated to the hepatitis B surface antigen . Virus-like particles (VLPs) are protein-based vaccines that stimulate high immune responses because of the VLPs’...
Investigational
Lactobacillus salivarius
Experimental
Medicago sativa top
Experimental
Nux vomica extract
Experimental
Displaying drugs 14601 - 14625 of 15379 in total